Elizabeth M Oliva1,2, Andrea Nevedal1, Eleanor T Lewis1,2, Matthew D McCaa1, Michael F Cochran3,4, P Eric Konicki5,6, Corey S Davis7, Christine Wilder8,9. 1. a Center for Innovation to Implementation , VA Palo Alto Health Care System , Menlo Park , California , USA. 2. b Program Evaluation and Resource Center , VA Office of Mental Health Operations , Menlo Park , California , USA. 3. c Department of Psychiatry and Behavioral Sciences , Stanford University School of Medicine , Stanford , California , USA. 4. d VA Palo Alto Health Care System , Menlo Park , California , USA. 5. e Louis Stokes Cleveland VA Medical Center , Cleveland , Ohio , USA. 6. f Department of Psychiatry , Case Western Reserve University School of Medicine , Cleveland , Ohio , USA. 7. g Network for Public Health Law , Los Angeles , California , USA. 8. h Cincinnati VA Medical Center , Cincinnati , Ohio , USA. 9. i Department of Psychiatry and Behavioral Neuroscience , University of Cincinnati College of Medicine , Cincinnati , Ohio , USA.
Abstract
BACKGROUND: In an effort to prevent opioid overdose mortality among Veterans, Department of Veterans Affairs (VA) facilities began implementing opioid overdose education and naloxone distribution (OEND) in 2013 and a national program began in 2014. VA is the first national health care system to implement OEND. The goal of this study is to examine patient perceptions of OEND training and naloxone kits. METHODS: Four focus groups were conducted between December 2014 and February 2015 with 21 patients trained in OEND. Participants were recruited from a VA residential facility in California with a substance use disorder treatment program (mandatory OEND training) and a homeless program (optional OEND training). Data were analyzed using matrices and open and closed coding approaches to identify participants' perspectives on OEND training including benefits, concerns, differing opinions, and suggestions for improvement. RESULTS: Veterans thought OEND training was interesting, novel, and empowering, and that naloxone kits will save lives. Some veterans expressed concern about using syringes in the kits. A few patients who never used opioids were not interested in receiving kits. Veterans had differing opinions about legal and liability issues, whether naloxone kits might contribute to relapse, and whether and how to involve family in training. Some veterans expressed uncertainty about the effects of naloxone. Suggested improvements included active learning approaches, enhanced training materials, and increased advertisement. CONCLUSIONS: OEND training was generally well received among study participants, including those with no indication for a naloxone kit. Patients described a need for OEND and believed it could save lives. Patient feedback on OEND training benefits, concerns, opinions, and suggestions provides important insights to inform future OEND training programs both within VA and in other health care settings. Training is critical to maximizing the potential for OEND to save lives, and this study includes specific suggestions for improving the effectiveness and acceptability of training.
BACKGROUND: In an effort to prevent opioid overdose mortality among Veterans, Department of Veterans Affairs (VA) facilities began implementing opioid overdose education and naloxone distribution (OEND) in 2013 and a national program began in 2014. VA is the first national health care system to implement OEND. The goal of this study is to examine patient perceptions of OEND training and naloxone kits. METHODS: Four focus groups were conducted between December 2014 and February 2015 with 21 patients trained in OEND. Participants were recruited from a VA residential facility in California with a substance use disorder treatment program (mandatory OEND training) and a homeless program (optional OEND training). Data were analyzed using matrices and open and closed coding approaches to identify participants' perspectives on OEND training including benefits, concerns, differing opinions, and suggestions for improvement. RESULTS: Veterans thought OEND training was interesting, novel, and empowering, and that naloxone kits will save lives. Some veterans expressed concern about using syringes in the kits. A few patients who never used opioids were not interested in receiving kits. Veterans had differing opinions about legal and liability issues, whether naloxone kits might contribute to relapse, and whether and how to involve family in training. Some veterans expressed uncertainty about the effects of naloxone. Suggested improvements included active learning approaches, enhanced training materials, and increased advertisement. CONCLUSIONS: OEND training was generally well received among study participants, including those with no indication for a naloxone kit. Patients described a need for OEND and believed it could save lives. Patient feedback on OEND training benefits, concerns, opinions, and suggestions provides important insights to inform future OEND training programs both within VA and in other health care settings. Training is critical to maximizing the potential for OEND to save lives, and this study includes specific suggestions for improving the effectiveness and acceptability of training.
Authors: Katherine Hadlandsmyth; Hilary J Mosher; Emine O Bayman; Justin G Wikle; Brian C Lund Journal: J Gen Intern Med Date: 2020-03-23 Impact factor: 5.128
Authors: Patricia Eckardt; Donald Bailey; Holli A DeVon; Cynthia Dougherty; Pamela Ginex; Cheryl A Krause-Parello; Rita H Pickler; Therese S Richmond; Eleanor Rivera; Carol F Roye; Nancy Redeker Journal: Nurs Outlook Date: 2020-04-09 Impact factor: 3.250
Authors: Shane R Mueller; Stephen Koester; Jason M Glanz; Edward M Gardner; Ingrid A Binswanger Journal: J Gen Intern Med Date: 2016-10-31 Impact factor: 5.128
Authors: Jason M Glanz; Komal J Narwaney; Shane R Mueller; Edward M Gardner; Susan L Calcaterra; Stanley Xu; Kristin Breslin; Ingrid A Binswanger Journal: J Gen Intern Med Date: 2018-01-29 Impact factor: 5.128
Authors: Geetanjoli Banerjee; E Jennifer Edelman; Declan T Barry; Stephen Crystal; Kirsha S Gordon; Adam J Gordon; Julie R Gaither; Traci C Green; Robert D Kerns; Ajay Manhapra; Brent A Moore; David A Fiellin; Brandon D L Marshall Journal: Pain Date: 2019-09 Impact factor: 7.926
Authors: Jaclyn M W Hughto; Lily K Gordon; Thomas J Stopka; Patricia Case; Wilson R Palacios; Abigail Tapper; Traci C Green Journal: Subst Abus Date: 2021-07-06 Impact factor: 3.984